Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CDK4 anticorps (N-Term)

Cet anticorps anti-CDK4 Monoclonal Lapin (Clone CDK4-8210R) (ABIN7860787) détecte spécifiquement CDK4 dans WB et IHC. L’anticorps est réactif avec des échantillons de Humain.
N° du produit ABIN7860787
639,45 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Recombinant CDK4 anticorps (N-Term) (ABIN7860787)

Antigène

Voir toutes CDK4 Anticorps
CDK4 (Cyclin-Dependent Kinase 4 (CDK4))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 165
  • 83
  • 67
  • 19
  • 8
  • 7
  • 5
  • 4
  • 3
  • 1
  • 1
  • 1
Humain

Hôte

  • 134
  • 49
  • 2
Lapin

Clonalité

  • 94
  • 90
Monoclonal

Conjugué

  • 115
  • 11
  • 9
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CDK4 est non-conjugé

Application

  • 145
  • 62
  • 48
  • 47
  • 44
  • 39
  • 24
  • 21
  • 14
  • 13
  • 7
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)

Clone

CDK4-8210R
  • Épitope

    • 19
    • 16
    • 16
    • 14
    • 9
    • 8
    • 8
    • 7
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Fonction

    Recombinant CDK4 Antibody

    Specificité

    Cyclin-dependent kinase-4 (CDK4) is a protein-serine kinase involved in the cell cycle. It is essential for the G1- to S-phase transition during the cell cycle and its expression is primarily controlled at the transcriptional level (PMID:17253961). CCND1- CDK4 axis is not only critical in glial tumor cells but also in stromal-derived cells in the surrounding tumor microenvironment that are vital to sustain tumor outgrowth (PMID:21844184). CDK4 is highly expressed in highly differentiated and dedifferentiated liposarcomas, but rarely expressed in other benign liposarcomas and other sarcomas. CDK4 and MDM2 combined to differentiate between highly differentiated liposarcoma (+), dedifferentiated liposarcoma (+) and myxoid liposarcoma, pleomorphic liposarcoma, spindle lipoma, pleomorphic lipoma and other high-grade sarcomas.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant fragment corresponding to N-terminal of human CDK4 protein

    Isotype

    IgG, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Antigène

    CDK4 (Cyclin-Dependent Kinase 4 (CDK4))

    Autre désignation

    CDK4

    Sujet

    CDK4 protein, CDK4_HUMAN, Cell division protein kinase 4, CMM3, Crk3, Cyclin dependent kinase 4, Melanoma cutaneous malignant 3, MGC14458, p34 cdk4, PSK-J3

    MCF7, HEK293T, cervical carcinoma and liposarcomas.|Human urothelial carcinoma, K-562

    Poids moléculaire

    34kDa

    ID gène

    1019, 95577

    UniProt

    P11802

    Pathways

    Cycle Cellulaire, Mitotic G1-G1/S Phases, Regulation of Cell Size
Vous êtes ici:
Chat with us!